经皮冠状动脉介入治疗后的微血管阻塞与无复流现象 - Suppr

Suppr

超能文献

Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.

作者信息

Jaffe Ronen, Charron Thierry, Puley Geoffrey, Dick Alexander, Strauss Bradley H

机构信息

Schulich Heart Programme, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Suite A-253, Toronto, Ontario, Canada.

出版信息

Circulation. 2008 Jun 17;117(24):3152-6. doi: 10.1161/CIRCULATIONAHA.107.742312.

DOI:10.1161/CIRCULATIONAHA.107.742312

PMID:18559715

Abstract

摘要

相似文献

Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.

Circulation. 2008 Jun 17;117(24):3152-6. doi: 10.1161/CIRCULATIONAHA.107.742312.

Intracoronary aspiration for bailout management of the no-reflow during percutaneous coronary intervention.

Int J Cardiol. 2006 May 24;109(3):402-5. doi: 10.1016/j.ijcard.2005.05.034. Epub 2005 Jun 20.

'The abrupt no-flow': a no-reflow like phenomenon in hypertrophic cardiomyopathy.

Eur Heart J. 2002 Jan;23(1):91-3. doi: 10.1053/euhj.2001.2944.

Vascular smooth muscle cell microparticles and coronary no-reflow: another piece of the puzzle?

Thromb Haemost. 2005 Oct;94(4):693-4. doi: 10.1160/TH05-08-0570.

Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes.

Circulation. 2009 Mar 10;119(9):1311-9. doi: 10.1161/CIRCULATIONAHA.108.831453.

Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis.

Coron Artery Dis. 2009 Jun;20(4):253-9. doi: 10.1097/MCA.0b013e32832ac5ac.

Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study.

Eur Heart J. 2009 Jun;30(11):1348-55. doi: 10.1093/eurheartj/ehp122. Epub 2009 Apr 21.

Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.

Eur Heart J. 2008 Aug;29(15):1843-50. doi: 10.1093/eurheartj/ehn325. Epub 2008 Jul 10.

Abrupt vessel closure after coronary angioplasty.

Nursing. 2008 Nov;38(11):72. doi: 10.1097/01.NURSE.0000341092.59813.a5.

Elevated admission cardiac troponin T is associated with microvascular dysfunction in acute myocardial infarction treated with emergency angioplasty.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):664-8. doi: 10.2459/JCM.0b013e3283252b32.

引用本文的文献

Efficacy of sonothrombolysis as an adjunct to primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: a systematic review and meta-analysis.

J Thromb Thrombolysis. 2025 Sep 9. doi: 10.1007/s11239-025-03176-1.

Network Pharmacology Approaches to Myocardial Infarction Reperfusion Injury: Exploring Mechanisms, Pathophysiology, and Novel Therapies.

Biomedicines. 2025 Jun 23;13(7):1532. doi: 10.3390/biomedicines13071532.

Coronary Microvascular Disease Early After Myocardial Infarction: Diagnostic Approach and Prognostic Value-A Narrative Review.

Biomedicines. 2025 May 23;13(6):1289. doi: 10.3390/biomedicines13061289.

Continuous mechanical aspiration thrombectomy for STEMI with high thrombus burden.

Cardiol J. 2025;32(4):407-410. doi: 10.5603/cj.102528. Epub 2025 Jun 12.

The Predictive Value of ALBI Score for No-Reflow in Non-ST Elevation Acute Coronary Syndrome.

J Clin Med. 2025 Apr 28;14(9):3035. doi: 10.3390/jcm14093035.

Sex-based Differences in Complications Following Percutaneous Coronary Interventions.

Curr Atheroscler Rep. 2025 Feb 17;27(1):33. doi: 10.1007/s11883-025-01278-y.

Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective.

Front Cardiovasc Med. 2025 Jan 14;11:1466961. doi: 10.3389/fcvm.2024.1466961. eCollection 2024.

Transcriptomic Analysis of Cardiac Tissues in a Rodent Model of Coronary Microembolization.

J Inflamm Res. 2024 Sep 23;17:6645-6659. doi: 10.2147/JIR.S469297. eCollection 2024.

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024.

Cardiovasc Interv Ther. 2024 Oct;39(4):335-375. doi: 10.1007/s12928-024-01036-y. Epub 2024 Sep 20.

A pilot study of perfusion balloon predilatation in conjunction with intracoronary nicorandil administration for acute coronary syndrome.

Cardiovasc Interv Ther. 2025 Jan;40(1):45-56. doi: 10.1007/s12928-024-01034-0. Epub 2024 Aug 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.

作者信息

Jaffe Ronen, Charron Thierry, Puley Geoffrey, Dick Alexander, Strauss Bradley H

机构信息

Schulich Heart Programme, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Suite A-253, Toronto, Ontario, Canada.

出版信息

Circulation. 2008 Jun 17;117(24):3152-6. doi: 10.1161/CIRCULATIONAHA.107.742312.

DOI:10.1161/CIRCULATIONAHA.107.742312

PMID:18559715

Abstract

摘要

相似文献

Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.

Circulation. 2008 Jun 17;117(24):3152-6. doi: 10.1161/CIRCULATIONAHA.107.742312.

Intracoronary aspiration for bailout management of the no-reflow during percutaneous coronary intervention.

Int J Cardiol. 2006 May 24;109(3):402-5. doi: 10.1016/j.ijcard.2005.05.034. Epub 2005 Jun 20.

'The abrupt no-flow': a no-reflow like phenomenon in hypertrophic cardiomyopathy.

Eur Heart J. 2002 Jan;23(1):91-3. doi: 10.1053/euhj.2001.2944.

Vascular smooth muscle cell microparticles and coronary no-reflow: another piece of the puzzle?

Thromb Haemost. 2005 Oct;94(4):693-4. doi: 10.1160/TH05-08-0570.

Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes.

Circulation. 2009 Mar 10;119(9):1311-9. doi: 10.1161/CIRCULATIONAHA.108.831453.

Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis.

Coron Artery Dis. 2009 Jun;20(4):253-9. doi: 10.1097/MCA.0b013e32832ac5ac.

Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study.

Eur Heart J. 2009 Jun;30(11):1348-55. doi: 10.1093/eurheartj/ehp122. Epub 2009 Apr 21.

Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.

Eur Heart J. 2008 Aug;29(15):1843-50. doi: 10.1093/eurheartj/ehn325. Epub 2008 Jul 10.

Abrupt vessel closure after coronary angioplasty.

Nursing. 2008 Nov;38(11):72. doi: 10.1097/01.NURSE.0000341092.59813.a5.

Elevated admission cardiac troponin T is associated with microvascular dysfunction in acute myocardial infarction treated with emergency angioplasty.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):664-8. doi: 10.2459/JCM.0b013e3283252b32.

引用本文的文献

Efficacy of sonothrombolysis as an adjunct to primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: a systematic review and meta-analysis.

J Thromb Thrombolysis. 2025 Sep 9. doi: 10.1007/s11239-025-03176-1.

Network Pharmacology Approaches to Myocardial Infarction Reperfusion Injury: Exploring Mechanisms, Pathophysiology, and Novel Therapies.

Biomedicines. 2025 Jun 23;13(7):1532. doi: 10.3390/biomedicines13071532.

Coronary Microvascular Disease Early After Myocardial Infarction: Diagnostic Approach and Prognostic Value-A Narrative Review.

Biomedicines. 2025 May 23;13(6):1289. doi: 10.3390/biomedicines13061289.

Continuous mechanical aspiration thrombectomy for STEMI with high thrombus burden.

Cardiol J. 2025;32(4):407-410. doi: 10.5603/cj.102528. Epub 2025 Jun 12.

The Predictive Value of ALBI Score for No-Reflow in Non-ST Elevation Acute Coronary Syndrome.

J Clin Med. 2025 Apr 28;14(9):3035. doi: 10.3390/jcm14093035.

Sex-based Differences in Complications Following Percutaneous Coronary Interventions.

Curr Atheroscler Rep. 2025 Feb 17;27(1):33. doi: 10.1007/s11883-025-01278-y.

Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective.

Front Cardiovasc Med. 2025 Jan 14;11:1466961. doi: 10.3389/fcvm.2024.1466961. eCollection 2024.

Transcriptomic Analysis of Cardiac Tissues in a Rodent Model of Coronary Microembolization.

J Inflamm Res. 2024 Sep 23;17:6645-6659. doi: 10.2147/JIR.S469297. eCollection 2024.

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024.

Cardiovasc Interv Ther. 2024 Oct;39(4):335-375. doi: 10.1007/s12928-024-01036-y. Epub 2024 Sep 20.

A pilot study of perfusion balloon predilatation in conjunction with intracoronary nicorandil administration for acute coronary syndrome.

Cardiovasc Interv Ther. 2025 Jan;40(1):45-56. doi: 10.1007/s12928-024-01034-0. Epub 2024 Aug 13.